Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Bucheon-si, Seongnam-si, Suwon, Uijeongbu-si, Yangsan, Busan, Daegu, Daejeon
2026-10-26
Not yet open
Seoul National University Hospital
Not applicable
3,000
Seongnam-si, Uijeongbu-si, Daegu, Seoul
2026-08-24
Not yet open
Uijeongbu St. Mary Hospital
Not applicable
580
Uijeongbu-si
2026-07-01
Not yet open
Seoul National University Hospital
Not applicable
150
Uijeongbu-si, Seoul
2026-06
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Wŏnju, Anyang-si, Seongnam-si, Suwon, Uijeongbu-si, Yangsan, Daegu, Daejeon
2026-05-11
Active, closed
EverEx Inc.
Not applicable
156
Guri-si, Gwangmyeong, Uijeongbu-si, Seoul
2026-03-19
Recruiting
Eli Lilly and Company
Phase 3
900
Daegu, Dongjak-gu, Seoul, Uijeongbu-si
2026-02-09
By invitation
Novo Nordisk A/S
Observational
500
Goyang-si, Seongnam-si, Suwon, Uijeongbu-si, Yangsan, Busan, Daegu, Daejeon
2025-11-10
Recruiting
Astellas Pharma Korea, Inc.
Observational
377
Goyang-si, Suwon, Uijeongbu-si, Yangsan, Hwasun Gun, Daejeon, Seoul
2025-04-03
Recruiting
AstraZeneca
Phase 3
990
Anyang-si, Daegu, Iksan-si, Jeonju, Seoul, Uijeongbu-si, Wŏnju
2025-03-18
Recruiting
Dianthus Therapeutics
Phase 3
256
Daegu, Daejeon, Seoul, Uijeongbu-si, Yangsan
2025-02-10
Recruiting
Endovision Co., Ltd.
Not applicable
286
Uijeongbu-si
2025-02-04
Recruiting
Seung-Jung Park
Observational
1,000
Seoul, Bucheon-si, Daegu, Gwangju, Ilsan, Sejong, Suwon, Uijeongbu-si
2025-01-09
Recruiting
Seoul St. Mary's Hospital
Not applicable
800
Incheon, Seoul, Suwon, Uijeongbu-si
2024-11-19
Recruiting
Boryung Pharmaceutical Co., Ltd
Observational
1,052
Seoul, Uijeongbu-si
2024-07-15
Recruiting
Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 1/2
330
Uijeongbu-si, Anyang-si, Busan, Daegu
2024-03-26
Active, closed
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
1,942
Busan, Daegu, Donggu, Goyang, Seoul, Uijeongbu-si, Ulsan
2024-03-13
Recruiting
AstraZeneca
Phase 3
5,250
Anyang-si, Busan, Daegu, Gwangju, Jeonju, Seoul, Uijeongbu-si, Ulsan
2024-02-21
Recruiting
Ascentage Pharma Group Inc.
Phase 3
333
Busan, Gyeonggi-do, Seoul, Uijeongbu-si
2024-02-05
Recruiting
Ascentage Pharma Group Inc.
Phase 3
350
Busan, Seoul, Uijeongbu-si
2023-08-31
Recruiting
Novartis Pharmaceuticals
Observational
600
Wŏnju, Anyang-si, Bucheon-si, Uijeongbu-si, Gyeonggi-do, Incheon, Seoul, Suwon
2023-07-19
Active, closed
Novartis Pharmaceuticals
Phase 3
383
Dongan-Gu, Anyang-Si, Guri-si, Uijeongbu-si, Jongno-gu, Seodaemun-gu, Seongbuk-Gu, Cheonan, Daejeon
2023-07-06
Active, closed
Novartis Pharmaceuticals
Phase 3
568
Bundang Gu, Uijeongbu-si
2022-11-21
Recruiting
Novartis Pharmaceuticals
Phase 4
347
Uijeongbu-si, Busan, Jeollanam, Seoul
2022-08-30
Active, closed
Yuhan Corporation
Observational
2,001
Chilgok, Chuncheon, Wŏnju, Bucheon-si, Uijeongbu-si, Iksan, Seoul, Busan
2022-06-24
Active, closed
Novartis Pharmaceuticals
Phase 3
405
Uijeongbu-si, Seoul
2021-10-06
Recruiting
Kiyuk Chang, MD,PhD
Phase 4
3,548
Bucheon-si, Suwon, Uijeongbu-si, Daejeon, Incheon, Seoul
2020-10-01
Recruiting
Il-Yang Pharm. Co., Ltd.
Phase 3
173
Uijeongbu-si
2018-06-25
Active, closed
National Cancer Center, Korea
Phase 3
5,224
Busan, Chuncheon, Daegu, Goyang, Gwangju, Incheon, Seoul, Uijeongbu-si
2014-06